News
The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...
8h
PsyPost on MSNPsychedelic retreats show promise in easing depression, PTSD, and reintegration struggles among veteransA new study has found that military veterans who attended retreats involving psychedelic substances like psilocybin or ...
Rebirth, for much of its runtime, remains in metaphor. It’s concerned with things that we don’t directly say but that have an ...
The FDA is raising efficacy questions over Lundbeck and Otsuka’s proposed combination of their Rexulti with Viatris’ Zoloft ...
The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...
An FDA advisory panel will meet July 18 to consider a supplemental new drug application for the antipsychotic brexpiprazole, ...
Fort Worth's Modern Art Museum hosts "HERE. IS. BETTER.," a PTSD-focused documentary screening. Admission is free with online ...
A woman said she felt "robbed" of her birth experience after a "painful" and "traumatic" delivery left her with ...
Kodiak Harbormaster and Borough Assemblyman Dave Johnson is back on the job after spending the past six weeks in therapy for ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...
A group of hikers in the Hollywood Hills confronted and detained a man Sunday accused of setting fire to trees and bushes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results